`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`JOINT STATUS REPORT
`
`Pursuant to the Court’s October 4, 2021 Order (D.I. 40), the parties provide this update
`
`
`
`v.
`
`
`
`
`
`
`
`Plaintiffs,
`
`Defendant.
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`
`
`
`C.A. No. 20-1524-LPS
`
`
`
`
`DAIICHI SANKYO, INC., DAIICHI
`SANKYO COMPANY, LIMITED, and
`ASTRAZENECA PHARMACEUTICALS LP,
`
`
`
`
`
`SEAGEN INC.,
`
`
`
`
`
`regarding the action pending in the Eastern District of Texas1, including their positions as to
`
`whether the current stay (expiring February 4, 2022) should be extended and/or how this case
`
`should proceed.
`
`
`
`Fact and expert discovery are complete in the Texas case, the parties are briefing
`
`dispositive motions and motions to strike expert testimony, and the parties have begun pretrial
`
`disclosures. See Ex. A (11/16/21 First Amended Docket Control Order). A jury trial before
`
`Judge Gilstrap is scheduled to begin on April 4, 2022. Id.
`
`
`
`In light of the foregoing, the parties respectfully submit that the stay of this action, which
`
`currently expires on February 4, 2022, should be extended another 90 days to permit the parties
`
`to reach mutual agreement as to (1) how to address Claims 6-8 of the ’039 patent, which
`
`do not overlap between the Texas action and this action and (2) whether the stay should be
`
`extended until the final adjudication of or dismissal of the Texas case.
`
`
`1 Seagen Inc. v. Daiichi Sankyo Company, Limited, No. 2:20-337 (E.D. Tex.) (“Texas case”).
`
`
`
`Case 1:20-cv-01524-LPS Document 41 Filed 02/01/22 Page 2 of 2 PageID #: 978
`
`
`
`
`
`
`ASHBY & GEDDES
`
`
`/s/ Steven J. Balick
`
`
`
`
`Steven J. Balick (No. 2114)
`Andrew C. Mayo (No. 5207)
`500 Delaware Avenue, 8th Floor
`P.O. Box 1150
`Wilmington, Delaware 19899
`(302) 654-1888
`sbalick@ashbygeddes.com
`amayo@ashbygeddes.com
`
`Attorneys for Plaintiffs Daiichi
`Sankyo, Inc. and Daiichi
`Sankyo Company, Limited
`
`
`MCCARTER & ENGLISH, LLP
`
`/s/ Daniel M. Silver
`
`
`
`
`Michael P. Kelly (No. 2295)
`Daniel M. Silver (No. 4758)
`Alexandra M. Joyce (No. 6423)
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, Delaware 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`Attorneys for Plaintiff
`AstraZeneca Pharmaceuticals LP
`
`Dated: February 1, 2022
`
`
`
`
`
`
`
`
`
`
`
`YOUNG CONAWAY STARGATT
`& TAYLOR, LLP
`
`/s/ Samantha G. Wilson
`
`
`
`
`Anne Shea Gaza (No. 4093)
`Samantha G. Wilson (No. 5816)
`Rodney Square
`1000 North King Street
`Wilmington, Delaware 19801
`(302) 571-6600
`agaza@ycst.com
`swilson@ycst.com
`
`Attorneys for Defendant
`
`
`
`2
`
`



